Literature DB >> 24290811

Neutral biodegradable lipid-envelope-type nanoparticle using vitamin A-Scaffold for nuclear targeting of plasmid DNA.

Hiroki Tanaka1, Hidetaka Akita2, Ryohei Ishiba1, Kota Tange3, Masaya Arai3, Kazuhiro Kubo3, Hideyoshi Harashima4.   

Abstract

Biomembranes and cytoplasm, a diffusion-limited region for nanoparticles are critical barriers to be overcome for the successful gene delivery. We herein report on a neutral, and intracellularly degradable lipid nanoparticle (LNP), containing encapsulated plasmid DNA (pDNA) that can be effectively delivered to the nucleus. A key material component in this particle is a vitamin A-scaffold SS-cleavable Proton-Activated Lipid-like Material ((SS)PalmA), which contains tertiary amine groups as proton sponge units that can respond to the acidic pH in endosomes, disulfide bonding for programmed collapse in the cytoplasm, and retinoic acid (RA) as a hydrophobic unit for assembly into LNP. LNP prepared using (SS)PalmA (LNP(PalmA)) exhibited a 15-fold higher gene expression activity compared to particles prepared with a simple acyl chain (myristoyl group)-scaffold one (LNPPalmM). Intracellular imaging studies revealed that LNP(PalmA) unexpectedly showed excessive endosome-disruptive characteristics. Furthermore, the decapsulation of pDNA slowly, but successively occurred in parallel with peri-nuclear accumulation. Nuclear targeting was blocked in the presence of native RA. Collectively, LNP(PalmA) is an intelligent particle that passes through the cytoplasm in particle form with the aid of the intrinsic nuclear transport system of RA, and thereafter releases its encapsulated pDNA for effective gene expression.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA; Drug delivery; Liposome; Nanoparticle; Retinoid

Mesh:

Substances:

Year:  2013        PMID: 24290811     DOI: 10.1016/j.biomaterials.2013.11.016

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Folic Acid/Peptides Modified PLGA-PEI-PEG Polymeric Vectors as Efficient Gene Delivery Vehicles: Synthesis, Characterization and Their Biological Performance.

Authors:  Chaoyu Liu; Yuancai Xie; Xiaohua Li; Xumei Yao; Xuanbin Wang; Min Wang; Zongxian Li; Fengjun Cao
Journal:  Mol Biotechnol       Date:  2020-11-03       Impact factor: 2.695

2.  Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.

Authors:  Masatoshi Maeki; Yuka Fujishima; Yusuke Sato; Takao Yasui; Noritada Kaji; Akihiko Ishida; Hirofumi Tani; Yoshinobu Baba; Hideyoshi Harashima; Manabu Tokeshi
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

Review 3.  Non-viral gene delivery systems for tissue repair and regeneration.

Authors:  Pan Wu; Haojiao Chen; Ronghua Jin; Tingting Weng; Jon Kee Ho; Chuangang You; Liping Zhang; Xingang Wang; Chunmao Han
Journal:  J Transl Med       Date:  2018-02-15       Impact factor: 5.531

Review 4.  Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes.

Authors:  Zesheng Cheng; Haiying Que; Li Chen; Qiu Sun; Xiawei Wei
Journal:  Pharmaceutics       Date:  2022-06-28       Impact factor: 6.525

Review 5.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles.

Authors:  Sei Yonezawa; Hiroyuki Koide; Tomohiro Asai
Journal:  Adv Drug Deliv Rev       Date:  2020-08-06       Impact factor: 15.470

6.  Toxoplasma gondii GRA15 DNA Vaccine with a Liposomal Nanocarrier Composed of an SS-Cleavable and pH-Activated Lipid-like Material Induces Protective Immunity against Toxoplasmosis in Mice.

Authors:  Tanjila Hasan; Ryo Kawanishi; Hidetaka Akita; Yoshifumi Nishikawa
Journal:  Vaccines (Basel)       Date:  2021-12-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.